ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 204 filers reported holding ROIVANT SCIENCES LTD in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328 | – | 285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $11,284,449 | 97.24% |
| QVT Financial LP | 122,541,536 | $1,235,218,683 | 67.65% |
| Patient Square Capital LP | 12,639,920 | $127,410,394 | 62.03% |
| Two Seas Capital LP | 7,909,591 | $79,728,677 | 17.43% |
| SB INVESTMENT ADVISERS (UK) LTD | 83,031,667 | $836,959,203 | 6.38% |
| Octagon Capital Advisors LP | 3,904,000 | $39,352,320 | 5.48% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $48,713,031 | 4.30% |
| VIKING GLOBAL INVESTORS LP | 75,238,700 | $758,406,096 | 3.10% |
| HSG Holding Ltd | 2,595,838 | $26,166,047 | 2.99% |
| Artia Global Partners LP | 824,363 | $8,309,579 | 2.86% |